Cenobamate

Category: Anticonvulsant

Cenobamate Overview

Cenobamate, sold under the brand name Xcopri, is for the treatment of partial-onset seizures in adults.[2][3] It was approved for medical use in the United States in November 2019[2][3][4] and placed in Schedule V in March 2020.[5] Contents 1 Pharmacology 1.1 Pharmacodynamics 2 History 3 References 4 Further reading 5 External links Pharmacology Pharmacodynamics Cenobamate is a voltage-...

Read more Cenobamate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cenobamate

Recent Cenobamate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Cenobamate: (5 results)

Sorted by National Drug Code

• 71699-102 Xcopri Maintenance PackXcopri Oral Kit by Sk Life Science, Inc.
• 71699-103 Xcopri Maintenance PackXcopri Oral Kit by Sk Life Science, Inc.
• 71699-201 Xcopri Titration PackXcopri Oral Kit by Sk Life Science, Inc.
• 71699-202 Xcopri Titration PackXcopri Oral Kit by Sk Life Science, Inc.
• 71699-203 Xcopri Titration PackXcopri Oral Kit by Sk Life Science, Inc.

Other drugs which contain Cenobamate or a similar ingredient: (1 result)

• XCOPRI Cenobamate